Substance Use Disorder Rates Higher in Patients With Comorbid SLE, Major Depressive Disorder

Patients with comorbid major depressive disorder were more likely to have a diagnoses of tobacco, alcohol, opioid, cannabis, stimulants, hallucinogens, sedatives-hypnotics, or anxiolytic use disorders compared to patients with only systemic lupus erythematous.

Related Keywords

San Francisco , California , United States , American , Xiaofeng Yan , Thomase Matson , Kaiser Permanente Washington Health Research Institute , American Psychiatric Association , Psychiatric Association , Substance Use Symptom Checklist ,